Dr. Serge Dibart, DMD
Claim this profileStudies Tooth Loss
1 reported clinical trial
2 drugs studied
More about Serge Dibart, DMD
Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Serge Dibart, DMD has experience with
- Conventional Chairside Fabrication Of Ti-Mesh Frame
- CAD-CAM Designed And Preprinted Ti-Mesh Frame
Breakdown of trials Serge Dibart, DMD has run
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Serge Dibart, DMD specialize in?
Serge Dibart, DMD focuses on Tooth Loss and other conditions. In particular, much of their work with Tooth Loss has involved treating patients, or patients who are undergoing treatment.
Is Serge Dibart, DMD currently recruiting for clinical trials?
No, Serge Dibart, DMD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Serge Dibart, DMD has studied deeply?
Yes, Serge Dibart, DMD has studied treatments such as Conventional chairside fabrication of Ti-Mesh frame, CAD-CAM designed and preprinted Ti-Mesh frame.
What is the best way to schedule an appointment with Serge Dibart, DMD?
Apply for one of the trials that Serge Dibart, DMD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.